Revolutionizing Aging: Venvalo Group Unveils Immorta Bio, Inc for Personalized Cell Therapy in Age-Related Disease Treatment
Venvalo Group, a venture value optimization firm, has recently announced the formation of Immorta Bio, Inc. This new regenerative medicine company is set to revolutionize the treatment of aging and diseases associated with aging by providing patient-specific therapeutic solutions. Pioneering Personalized Regenerative Medicine Immorta Bio, Inc. is spearheading the development of personalized stem cell technologies, […]